Novo Nordisk A/S (NVO)

Novo Nordisk Market Cap

Novo Nordisk has a market cap or net worth of $221.55 billion as of July 20, 2026. Its market cap has decreased by -22.84% in one year.

• Market Cap: 221.55B
• Enterprise Value: 240.59B
• 1-Year Change: -22.84%
• Ranking: #63
• Category: Mega-Cap
• Stock Price: $49.61

Market Cap Chart

Chart

Since December 1, 1998, Novo Nordisk's market cap has increased from $5.15B to $221.55B, an increase of 4,197.92%. That is a compound annual growth rate of 14.57%.

Market Cap History

Date	Market Cap	% Change
Jul 20, 2026	221.55B	-2.00%
Dec 31, 2025	226.09B	-41.72%
Dec 31, 2024	387.95B	-17.76%
Dec 29, 2023	471.73B	54.12%
Dec 30, 2022	306.08B	19.24%
Dec 31, 2021	256.69B	55.86%
Dec 31, 2020	164.70B	16.14%
Dec 31, 2019	141.81B	23.12%
Dec 31, 2018	115.18B	-15.84%
Dec 29, 2017	136.86B	46.79%
Dec 30, 2016	93.24B	-38.18%
Dec 31, 2015	150.82B	29.59%
Dec 31, 2014	116.38B	12.48%
Dec 31, 2013	103.47B	9.30%
Dec 31, 2012	94.66B	36.88%
Dec 30, 2011	69.16B	-0.91%
Dec 31, 2010	69.79B	72.41%
Dec 31, 2009	40.48B	26.82%
Dec 31, 2008	31.92B	-22.43%
Dec 31, 2007	41.15B	52.03%
Dec 29, 2006	27.07B	44.82%
Dec 30, 2005	18.69B	1.87%
Dec 31, 2004	18.35B	29.73%
Dec 31, 2003	14.14B	41.73%
Dec 31, 2002	9.98B	25.01%

View and export this data all the way back to 1998. Sign Up Today.

Data Source: Nasdaq Data Link Last updated: Jul 17, 2026

Market cap data is provided by Nasdaq Data Link. The current market cap updates continuously throughout the trading day, while the historical market cap is updated daily after market close.

Update frequency:

Daily

Last checked:

Jul 20, 2026

Data Sources Report a data error

Related Stocks

Company	Market Cap
Johnson & Johnson	609.12B
AbbVie	449.63B
Merck & Co.	314.90B
Novartis AG	283.75B
AstraZeneca	262.79B
Amgen	197.69B
Gilead Sciences	166.72B
Pfizer	142.77B